Xiuning Le

Targets

• EGFR 2
• HER2 1
• MET 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Jan 2026

• Publication

  Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.

  NPJ precision oncology, Jan 2026

• Publication

  Precision oncology in resected EGFR-mutant NSCLC.

  The Lancet. Oncology, Jan 2026

• Publication

  Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer.

  European radiology, Dec 2025

• Publication

  Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood.

  Nature communications, Dec 2025

• Publication

  MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

  Cancers, Nov 2025

• Publication

  Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approaches.

  Nature reviews. Clinical oncology, Nov 2025

• Publication

  Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients.

  Cancers, Oct 2025

Affiliations

• The University of Texas MD Anderson Cancer Center

Co-authors

• JWJia WuHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.